Cargando…
Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma
Tumor-induced osteomalacia is a rare acquired metabolic bone disorder characterized by isolated renal phosphate wasting due to abnormal tumor production of fibroblast growth factor 23. We report the case of a 59 year old woman referred to our department with a long history of progressive diffuse mus...
Autores principales: | Slot-Steenks, Mathilde M. Bruins, Hamdy, Neveen A.T., van de Sande, Michiel A.J., Vriens, Dennis, Cleven, Arjen H.G., Appelman-Dijkstra, Natasha M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107201/ https://www.ncbi.nlm.nih.gov/pubmed/27709474 http://dx.doi.org/10.1007/s12020-016-1092-5 |
Ejemplares similares
-
Hypercalcemia during pregnancy: management and outcomes for mother and child
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2021) -
A Pragmatic Clinical Trial to Compare the Real-World Effectiveness of V-Go versus Standard Delivery of Insulin in Patients with Advanced Type 2 Diabetes
por: Cziraky, Mark J., et al.
Publicado: (2019) -
Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model
por: Wahlqvist, Peter, et al.
Publicado: (2018) -
Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses
por: Schneider, John E., et al.
Publicado: (2018) -
Cost Savings and Reduced Health Care Utilization Associated with Participation in a Digital Diabetes Prevention Program in an Adult Workforce Population
por: Sweet, Cynthia Castro, et al.
Publicado: (2020)